Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > I see 3.12M lost in the Q3...and that is just fine!

<< Previous

Bullboard Posts

Next >>

Comment by cashascarson Dec 11, 2021 6:15pm

640 Views

Post# 34222282

RE:I see 3.12M lost in the Q3...and that is just fine!

Your really coming up with the bull now. Your saying we are losing 3.12 million per quarter when the release clearly says it's a loss for the first 9 months of their Corp year. They make comment in the release:

The anti-cancer therapy (ACT) division represented $2,325,340 of this loss (74 per cent) for the nine-month period ended Sept. 30, 2021.

So stop talking crapp if you can't even read a financial statement properly. Your deception does not work here no matter how often you post your nonsense.
cashascars

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages